We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
(-1.9%)
Cap. Flow
-$982M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$250M |
| 2 |
Starbucks
SBUX
|
+$152M |
| 3 |
CERN
Cerner Corp
CERN
|
+$122M |
| 4 |
Colgate-Palmolive
CL
|
+$87.1M |
| 5 |
Procter & Gamble
PG
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$456M |
| 2 |
Cisco
CSCO
|
+$392M |
| 3 |
Analog Devices
ADI
|
+$151M |
| 4 |
United Parcel Service
UPS
|
+$148M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Consumer Discretionary | 15.92% |
| 3 | Financials | 12.69% |
| 4 | Healthcare | 12.47% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CADE
276
DELISTED
Cadence Bank
CADE
| $16.4M | 0.03% |
516,359
-23,607
| -4% | -$777K |
|
277
Home Depot
HD
$355B
| $16.3M | 0.03% |
91,400
-2,191
| -2% | -$411K |
|
278
RPC Inc
RES
$1.3B
| $16.3M | 0.03% |
901,635
-45,761
| -5% | -$959K |
|
279
Costco
COST
$420B
| $16.2M | 0.03% |
85,886
+2,412
| +3% | +$455K |
|
280
Estee Lauder
EL
$32B
| $16.1M | 0.03% |
107,692
+2,053
| +2% | +$284K |
|
|
281
CALL
Home Depot
HD
$355B
| $16.1M | 0.03% |
+90,200
| New | +$16.9M |
|
282
Compass Minerals
CMP
$1.15B
| $16.1M | 0.03% |
266,470
-3,591
| -1% | -$241K |
|
283
FedEx
FDX
$75.4B
| $15.9M | 0.03% |
66,422
-459
| -0.7% | -$116K |
|
284
Advanced Energy
AEIS
$13B
| $15.9M | 0.03% |
249,266
+85,321
| +52% | +$5.9M |
|
285
American Water Works
AWK
$26.9B
| $15.9M | 0.03% |
193,804
-36,877
| -16% | -$3.01M |
|
|
AMED
286
DELISTED
Amedisys
AMED
| $15.9M | 0.03% |
+263,437
| New | +$15M |
|
|
NLSN
287
DELISTED
Nielsen Holdings plc
NLSN
| $15.7M | 0.03% |
493,326
+18,235
| +4% | +$631K |
|
288
Sensata Technologies
ST
$6.79B
| $15.6M | 0.03% |
+301,184
| New | +$16.1M |
|
289
Diamondback Energy
FANG
$52.7B
| $15.4M | 0.03% |
121,779
+6,153
| +5% | +$775K |
|
|
CSFL
290
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $15.2M | 0.03% |
573,654
-28,562
| -5% | -$765K |
|
|
GHDX
291
DELISTED
Genomic Health, Inc.
GHDX
| $15.2M | 0.03% |
486,277
-11,777
| -2% | -$391K |
|
|
WAGE
292
DELISTED
WageWorks, Inc.
WAGE
| $15.1M | 0.03% |
334,693
-121,384
| -27% | -$6.63M |
|
293
Standex International
SXI
$4.12B
| $15.1M | 0.03% |
157,977
-7,303
| -4% | -$731K |
|
294
Allstate
ALL
$67.5B
| $15M | 0.03% |
157,955
-2,119
| -1% | -$205K |
|
295
Humana
HUM
$46.2B
| $15M | 0.03% |
55,697
-8,553
| -13% | -$2.32M |
|
296
Altria Group
MO
$114B
| $14.9M | 0.03% |
239,845
-822
| -0.3% | -$54.4K |
|
297
Coherent
COHR
$74.2B
| $14.9M | 0.03% |
365,294
-500,662
| -58% | -$21.7M |
|
298
Microchip Technology
MCHP
$46B
| $14.9M | 0.03% |
326,306
-63,686
| -16% | -$2.93M |
|
299
CSX Corp
CSX
$93.1B
| $14.9M | 0.03% |
802,536
+72,447
| +10% | +$1.35M |
|
300
Eaton
ETN
$174B
| $14.9M | 0.03% |
186,149
-29,991
| -14% | -$2.46M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2018 Portfolio in Review
As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
- Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
- Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
- Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
- Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
- Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.